Active, not recruitingNCT03782610
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Studying Arterial duct anomaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nationwide Children's Hospital
- Principal Investigator
- Jonathan L Slaughter, MD, MPH, M.DNationwide Children's Hospital/The Ohio State University
- Enrollment
- 526 enrolled
- Eligibility
- All sexes
- Timeline
- 2019 – 2026
Study locations (4)
- Nationwide Children's Hospital Main Campus Neonatal Intensive Care Unit, Columbus, Ohio, United States
- Nationwide Children's Neonatal Intensive Care Unit at The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- Nationwide Children's Neonatal Intensive Care Unit at OhioHealth Riverside Methodist Hospital, Columbus, Ohio, United States
- Nationwide Children's Hospital Neonatal Intensive Care Unit at OhioHealth Grant Medical Center, Columbus, Ohio, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Ohio State University · OhioHealth · Mount Carmel Health System
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03782610 on ClinicalTrials.govOther trials for Arterial duct anomaly
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06950164Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational StudyDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNCT06658496PDA for Kidneys StudyUniversity of Wisconsin, Madison
- RECRUITINGNCT06646250NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation PilotSt. Olavs Hospital
- RECRUITINGPHASE2NCT07143201Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCTHamilton Health Sciences Corporation
- RECRUITINGNCT05264753Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus DefectsOcclutech International AB
- ACTIVE NOT RECRUITINGNCT04371081Amplatzer Piccolo Occluder Japan Post-marketing Database SurveillanceAbbott Medical Devices
- ENROLLING BY INVITATIONNANCT04667455Improving Care for Children With Congenital Heart Disease.Lund University Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT03456336Management of the PDA TrialNICHD Neonatal Research Network